hers compounded semaglutide safety Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle An update from hims/hers: Compounded

Workers with obesity have roughly 76% higher short-term disability rates than their normal-weight colleagues, meaning every employee who gains stable access to effective obesity treatment is statistically far less likely to go out on disability leave

As tirzepatide leaves your system, its glucose-lowering effects will diminish, and blood sugar levels may rise toward pre-treatment values

GLP-1 (glucagon-like peptide-1) Investigated in research related to appetite signalling, gastric motility, and glucose regulation

Mochi Healths Public Response In its own public statement, Mochi Health framed the lawsuit as part of a broader pattern of large pharmaceutical companies challenging smaller, more affordable healthcare alternatives

Inoue, K., Hisatomi, A., Umeda, F

Med Sci Monit